Institut für Technologieentwicklung in der Strahlentherapie – radART
Publikationen

The OligoPanc project

Carl-Stephan Leonhardt, Mustapha Adham, Shouki Bazarbashi, Irit Ben-Aharon, Regina G. H. Beets-Tan, Ugo Boggi, Thomas B. Brunner, Francesco Cellini, Arturo Chiti, Lois Daamen, Berardino De Bari, Sara De Dosso, Michel Ducreux, Cathy Eng, Massimo Falconi, Cristina R. Ferrone, Isabella Frigerio, Ingrid Garajova, Sabine Gerum, Michael Ghadimi, Thomas Gruenberger, Pascal Hammel, Karin Haustermans, Maria Hawkins, Jin He, Hanne D. Heerkens, Florence Huguet, Martijn P. W. Intven, Ulla Klaiber, Tiuri E. Kroese, Pierre Laurent-Puig, Florian Lordick, Ethan B. Ludmir, Teresa Macarulla, Oscar Matzinger, Alessio G. Morganti, Somnath Mukherjee, Eileen M. O'Reilly, Joon Oh Park, Demetris Papamichael, Per Pfeiffer, Jose M. Ramia, Falk Roeder, Erika Ruiz-Garcia, Sohei Satoi, Marta Scorsetti, Martin Schneider, Thomas Seufferlein, Alejandro Serrablo, Shailesh V. Shrikhande, Elizabeth C. Smyth, Magali Svrcek, Kyoichi Takaori, Margaret A. Tempero, Natalia S. Tissera, Jeanne Tie, Orlando J. M. Torres, Anthony Turpin, Eric Van Cutsem, Eva Versteijne, Caterina Vivaldi, Zev A. Wainberg, Ralph R. Weichselbaum, Juergen Weitz, Christopher L. Wolfgang, Gerald W. Prager, Oliver Strobel , SOCIETY; Oncology;

MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients

Alexandra Hochreiter, Markus Stana, Marisa Klebermass, Elvis Ruznic, Brane Grambozov, Josef Karner, Martin Heilmann, Danijela Minasch, Ayurzana Purevdorj, Georg Gruber, Raphaela Moosbrugger, Falk Roder, Franz Zehentmayr , Durvalumab; Non-small cell lung cancer; Allstar; Mlr; Rwd; Blood biomarkers; dMLR;

Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III

Franz Zehentmayr, Josef Karner, Markus Stana, Elvis Ruznic, Barbara Zellinger, Marisa Klebermass, Ayurzana Purevdorj, Georg Gruber, Danijela Minasch, Martin Heilmann, Raphaela Moosbrugger, Falk Roeder, Brane Grambozov , Elderly; NSCLC; Durvalumab; Radiation oncology; Sequential radiotherapy;

Stereotactic Body Radiotherapy vs. Metastasectomy for Soft Tissue and Bone Sarcoma Lung Metastases - A Systematic Review analyzing Safety and Efficacy

Lena Kretzschmar, Maksym Fritsak, Philip Heesen, Astrid Heusel, Sylvie Bonvalot, Matthias Guckenberger, Aisha Miah, Falk Roder, Maria Anna Smolle, Sebastian M. Christ, Siyer Roohani , SURGERY; TOXICITY; Outcome; Oligometastatic; Pulmonary metastasis; Sbrt; Sarcoma;

Delta Changes in [18F]FDG PET/CT Parameters Can Prognosticate Clinical Outcomes in Recurrent NSCLC Patients Who Have Undergone Reirradiation–Chemoimmunotherapy

Brane Grambozov, Nazanin Zamani-Siahkali, Markus Stana, Mohsen Beheshti, Elvis Ruznic, Zarina Iskakova, Josef Karner, Barbara Zellinger, Sabine Gerum, Falk Roeder, Christian Pirich, Franz Zehentmayr , 18f-fdg-pet-ct; Image biomarkers; Non-small cell lung cancer; Reirradiation;

Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM Approaches

Sara Vockner, Matthias Mattke, Ivan M. Messner, Christoph Gaisberger, Franz Zehentmayr, Klarissa Ellmauer, Elvis Ruznic, Josef Karner, Gerd Fastner, Roland Reitsamer, Falk Roeder, Markus Stana , deep learning; Automatic segmentation; Cone beam computed tomography; Intraoperative electron radiotherapy;

Durvalumab prolongs overall survival whereas radiation dose escalation >66 Gy improves long-term local control in unresectable NSCLC stage III: Updated analysis of the Austrian radio-oncological lung cancer study association registry (ALLSTAR)

Franz Zehentmayr, Petra Feurstein, Elvis Ruznic, Brigitte Langer, Brane Grambozov, Marissa Klebermass, Ayurzana Purevdorj, Georg Gruber, Danijela Minasch, Martin Heilmann, B. Breitfelder, Claudia Steffal, Gisela Gastinger-Grass, Karoline Kirchhammer, M. Kazil, Heidi Stranzl, Karin Dieckmann

203P: Immunotherapy improves clinical outcome in KRAS mutated patients with unresectable NSCLC stage III: A subcohort analysis of the Austrian radio-oncological lung cancer study association regristry (ALLSTAR)

Franz Zehentmayr, Marisa Klebermass, Barbara Zellinger, B. Langer, Brane Grambozov, Ayurzana Purevdorj, Josef Karner, Georg Gruber, Markus Stana, Danijela Minasch, K. Kirchhammer, C. Steffal, H. Stranzl, Raphaela Moosbrugger, Petra Feurstein, Karin Dieckmann, Elvis Ruznic

1870 Delta changes in 18-FDG PET/CT parameters can prognosticate clinical outcomes in recurrent NSCLC patients who have undergone reirradiation

Brane Grambozov, Nazanin Zamani-Siahkali, Markus Stana, Mohsen Beheshti, Elvis Ruznic, Zarina Iskakova, Josef Karner, Barbara Zellinger, Sabine Gerum, Falk Röder, Christian Pirich, Franz Zehentmayr

Durvalumab impacts progression-free survival while high-dose radiation > 66 Gy improves local control without excess toxicity in unresectable NSCLC stage III

Franz Zehentmayr, Petra Feurstein, Elvis Ruznic, Brigitte Langer, Brane Grambozov, Marisa Klebermass, Herbert Huepfel, Johann Feichtinger, Danijela Minasch, Martin Heilmann, Barbara Breitfelder, Claudia Steffal, Gisela Gastinger-Grass, Karoline Kirchhammer, Margit Kazil, Heidi Stranzl, Karin Dieckmann, , TOXICITY; Durvalumab; Local control; Non-operable NSCLC; Total radiation dose;

Toxicity and cosmetic outcome after Intraoperative Radiotherapy with Electrons (IOERT) to the partial breast during breast conserving surgery of breast cancer patients in early stages

G. Fastner, R. Reitsamer, C. Gaisberger, M. Stana, C. Fussl, M. Mattke, B. Grambozov, F. Zehentmayr, A. Sir, N. Annon-Eberharter, F. Roeder

Patterns of Temporal Lobe Reaction and Radiation Necrosis after Particle Radiotherapy in Patients with Skull Base Chordoma and Chondrosarcoma-A Single-Center Experience

Matthias Mattke, Matteo Ohlinger, Nina Bougatf, Robert Wolf, Thomas Welzel, Falk Röder, Sabine Gerum, Christoph Fussl , Natalee Annon-Eberharter, Malte Ellerbrock, Oliver Jäkel, Thomas Haberer, Klaus Herfarth, Matthias Uhl, Jürgen Debus, Katharina Seidensaal, Semi Harrabi

First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer

Falk Roeder, Gerd Fastner, Christoph Fussl, Felix Sedlmayer, Markus Stana, Johannes Berchtold, Tarkan Jäger, Jaroslav Presl, Philipp Schredl, Klaus Emmanuel, Daniela Colleselli, Gabriel Kotolacsi, Philipp Scherer, Philipp Steininger, Christoph Gaisberger , Humans; ELECTRONS; Radiotherapy, Image-Guided/methods; Rectal Neoplasms/diagnostic imaging; Combined Modality Therapy; Cone-Beam Computed Tomography; Intraoperative Period; Intraoperative Care;

Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?

J. Berchtold, C. Winkler, J. Karner, M. Groher, C. Gaisberger, F. Sedlmayer, F. Wolf , SYSTEM; LOCALIZATION; RADIOTHERAPY; Noninvasive tracking; Prostate motion management; Image-guidance alternatives; Radiosurgery; Margins;

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate

Markus Stana, Brane Grambozov, Josef Karner, Isabella Gollner, Christoph Gaisberger, Elvis Ruznic, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr , VOLUME; MORTALITY; SURVIVAL; PHASE-III; CELL LUNG-CANCER; CISPLATIN; CONFORMAL RADIOTHERAPY; CONCURRENT; SEQUENTIAL CHEMORADIOTHERAPY; CAPACITY PREDICTS;

Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.

Brane Grambozov, Forough Kalantari, Mohsen Beheshti, Markus Stana, Josef Karner, Elvis Ruznic, Barbara Zellinger, Felix Sedlmayer, Gabriel Rinnerthaler, Franz Zehentmayr , SURVIVAL; LOCAL-CONTROL; RADIOTHERAPY; POSITRON-EMISSION-TOMOGRAPHY; METABOLIC TUMOR VOLUME; CELL LUNG-CANCER; DEFINITIVE CHEMORADIATION THERAPY; STANDARDIZED UPTAKE VALUE; F-18-FDG PET; STAGE;

Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3

E. Ruznic, B. Zellinger, U. Bodenhofer, IA Engländer, C. Kronberger, B. Grambozov, M. Stana, J. Karner, G. Fastner, K. Sotlar, F. Sedlmayer, F. Zehentmayr

Investigating focal spot position drift in a mobile imaging system equipped with a monobloc-based x-ray generator

IM Messner, P. Keuschnigg, B. Stoellinger, M. Kraihamer, J. Coste-Marin, P. Huber, D. Kellner, EM Kreuzeder, P. Steininger, H. Deutschmann , CT; focal spot drift; focal spot shift; high resolution imaging; ImagingRing mobile; IRm; Loop-X; misalignment artifact; off-focal radiation; thermal focal spot drift; BEAM; CALIBRATION;

Practice of Radiation Therapy for SCC esophageal cancer in Austria - A Survey of the OGRO-GIT-Group

S. Gerum, W. Iglseder, P. Clemens, P. Harl, R. Jaeger, T. Knocke-Abulesz, G. Kurzweil, K. Peterka, I. Reiter, J. Salinger, R. Schmid, S. Schwaiger, H. Stranzl-Lawatsch, C. Venhoda, F. Sedlmayer, F. Roeder

Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III

Markus Stana, Brane Grambozov, Christoph Gaisberger, Josef Karner, Elvis Ruznic, Johannes Berchtold, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr , THERAPY; VALIDATION; IMPACT; RADIOTHERAPY; COMBINED PULMONARY-FIBROSIS; DENSITY CHANGES; EMPHYSEMA; PNEUMONITIS;